CD9 and rheumatoid arthritis: Stratification according to treatment response revealed that the difference detected in RA patients prior to treatment (Fig. 3c) could largely be attributed to the non-responders, as they displayed the highest concentration of CD9 captured sEVs (Fig. 4a).